The Department for BioMedical Research (DBMR) of the Faculty of Medicine of the University of Bern, led by Prof. Mark A. Rubin, MD, was established in 1994 by the University of Bern and the Inselspital (Bern University Hospital). The DBMR is divided in 13 Research Programs with about 100 participating individual labs and several Independent Research Labs whose research spans across all biomedical fields. To realize its mission to bridge the gap between bench and bedside, the DBMR promotes an integrative perspective to clinical research with a strong emphasis in the development of translational approaches, the use of omics and other cutting-edge technologies, and extensive interaction and collaboration between laboratory-based and patient-oriented clinical research. The DBMR is also committed to fostering the careers of young academics.
The DBMR informs employees about current measures in connection with the Coronavirus. The information is updated on an ongoing basis, most recently on September 01.
Upcoming Course: Conventional fluorescence microscopy, laser scanning
microscopy and digital image processing. 13.09.2021 - 15.09.2021
DBMR Supply Center will be temporarily shut-down from 1. August 2021 until sometime after 1. October 2021. For more information please see Supply Center Website.
Congratulations to PD Dr. Marianna Kruithof-de Julio and Prof. Dr. Eliane J. Müller on each receiving a SNF Sinergia Grant.
ERC Advanced Grants Call (AdG) 2021 is open until August 31
ERC Advanced Grants support excellent researchers who have a track-record of significant research achievements in the last 10 years with up to € 2.5million for a period of 5 years.
SNF NRP79 Advancing 3R call is open
The National Research Programme 79 “Advancing 3R – Animals, Research and Society” (NRP 79) has been launched. Interested researchers can submit their pre-proposals until 3 August 2021.
At the outset of the May 3 DBMR Research Conference, Prof. Dr. med. Daniel M. Aebersold announced the winners of the 2020 Benoît Pochon Prize.
The prize went to Dr. med. Haitang Yang and Dr. Nicolas Melin. The DBMR congratulates the two winners. Read more
We welcome Prof. Anne Angelillo-Scherrer (Deputy Director), Dr. Marianna Kruithof-de Julio, Prof. Volker Enzmann and Prof. Carsten Riether to the DBMR Board of Directors for a period of two years and look forward to the involvement of active research members of the DBMR in the inter-workings of the department!
Today we are happy to inform you about 3 upcoming MIC online trainings in February and March. These trainings are free and open to everyone who is interested in microscopy. You can find some information and ILIAS links for registration (login required) below.
The contractual negotiations between swissuniversities and Springer Nature Verlag have finally been concluded, so we were able to license Nature Cancer and access is possible at https://www.nature.com/natcancer/.
Researchers at the University of Bern led an international team that has identified a novel vulnerability in advanced prostate cancer that is no longer responding to hormonal therapy. These findings could lead to the development of new treatment approaches for men suffering from the most aggressive form of prostate cancer.
Congratulations to Dr Marianna Kruithof-de-Julio and Prof. Mark Rubin, DBMR, on their 3Rs project award. With this 3RCC funding they will develop a platform for GU cancer patient-derived organoids.
3rd July 2020, 13.00 – 15.30, E0.211, sitem-insel, Freiburgstrasse 3, Bern
Video conference session: https://tinyurl.com/y7ehc3jo
Sitem-insel school would like to invite all its partners, University of Bern students and Inselspital members to attend the project presentation session of this year’s CAS Artificial Intelligence in Medical Imaging, scheduled for 3rd July 2020 between 13:00 – 15:30
Erste multizentrische Studie der Lunge zu oft auftretenden Langzeitschäden bei Ex-COVID-19 Patienten startet unter Leitung von PD. Manuela Funke-Chambour am Universitätsspital Bern. Kooperation mit @Unispital_USZ, @KantonsspitalSG u.a.m. ist vorgesehen.
Martin Bachmann, Gruppenleiter am Departement for Biomedical Research @DBMR_UniBe der #unibern, forscht seit Januar an einem Impfstoff gegen CoViD19.
+41 31 632 09 98